@FiercePharma: So why would Pfizer walk away from its $200M upfront for the Biocon diabetes deal? Item | Follow @FiercePharma
> Pfizer's ($PFE) Prevnar 13 vaccine proved effective in a study in children 5 to 17 years of age, which could be a new market for the company's third-best-selling product. News
> Scottish officials refused to recommend Johnson & Johnson's ($JNJ) prostate cancer pill Zytiga for use by its health service, saying its cost was not justified by its benefits. Item
> The U.K.'s cost-effectiveness gatekeepers asked for more information about long-term use of Bayer's anticoagulant Xarelto to treat and prevent certain types of blood clots. Report
> GlaxoSmithKline ($GSK) tapped India's Infosys and Britain's Fabric Worldwide for software and digital marketing services to support the drugmaker's global campaigns. Story
> Jordan's Hikma Pharmaceuticals is scouting for acquisitions in Turkey. Report
> Ranbaxy Laboratories opened its new manufacturing facility in Morocco, anticipating growth in Africa's $1 billion drug market. Article
Biotech News
@FierceBiotech: Beefed-up aspirin, charged with gas, conquers colon cancer in lab. Item | Follow @FierceBiotech
@JohnCFierce: Hwang Woo-Suk is an oddly compelling character. Convicted in a scandal that would have destroyed anyone, still moving on. Story | Follow @JohnCFierce
@RyanMFierce: FDA advisers back J&J, Pfizer efforts to start testing controversial arthritis pain meds. Story | Follow @RyanMFierce
@FierceMedDev: Consumer Reports taps ire over bad medical devices. News | Follow @FierceMedDev
> FDA scientists see improved integrity, but complaints of interference still common. News
> Regulators start thinking creatively about new approval pathway. Report
> Omeros touts promising PhIII for ophthalmology treatment. Story
> NicOx spikes on successful glaucoma drug study. More
> Pfizer walks away from $350M insulin pact with India's Biocon. News
> FDA panel backs effort to lift class hold on anti-NGF pain drugs. Item
Biotech Research News
> Stem cells end need for anti-rejection meds in some kidney transplant patients. Item
> U.K. research knocks wind out of personalized medicine push. Report
> Antibody blocks advance of Alzheimer's plaque in mice. Story
> Glaucoma-stricken rats see better, thanks to stem cells. Article
> Beefed-up aspirin, charged with gas, conquers colon cancer in lab. News
> RhoGDI2 protein hampers bladder cancer metastasis. Story
Manufacturing News
> Fire at Sandoz plant complicates drug shortages. Item
> Litigation: Sanofi, Genzyme 'negligently allowed a virus contamination in the manufacturing facility.' News
> Loss of manufacturing contract takes toll on Patheon. Report
> U.K. drug regulator asks industry to name the rules it wants to go. Story
> FDA says 5 years of Warner Chilcott's Ovcon BC pills suspect. Item
> WHO joins agencies in beefing up inspections of API facilities. Article
And Finally ... New research hints that younger patients using statins may have a lower risk of developing Parkinson's disease. Report